Gilead Sciences (GILD) Long-Term Investments (2009 - 2026)

Gilead Sciences (GILD) has reported Long-Term Investments for 17 consecutive years, with $983.0 million the latest figure, recorded in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $983.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $983.0 million (changed N/A YoY), and the FY2025 annual result was $3.0 billion, changed N/A from the prior year.
• Long-Term Investments was $983.0 million for Q1 2026 at Gilead Sciences, down from $3.0 billion in the prior quarter.
• Over five years, Long-Term Investments peaked at $3.0 billion in Q4 2025 and troughed at $983.0 million in Q1 2026.
• Average Long-Term Investments over 4 years is $1.5 billion, with a median of $1.3 billion recorded in 2023.
• Year-over-year, Long-Term Investments soared 146.46% in 2022 and retreated 9.83% in 2023.
• Over 4 years, Long-Term Investments stood at $1.2 billion in 2022, then fell by 6.59% to $1.2 billion in 2023, then jumped by 155.72% to $3.0 billion in 2025, then plunged by 66.95% to $983.0 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $983.0 million in Q1 2026, $3.0 billion in Q4 2025, and $2.0 billion in Q3 2025.